首页> 外文期刊>Southern Medical Journal >WDHA (watery diarrhea, hypokalemia, achlorhydria) syndrome: clinical features, diagnosis, and treatment.
【24h】

WDHA (watery diarrhea, hypokalemia, achlorhydria) syndrome: clinical features, diagnosis, and treatment.

机译:WDHA(水性腹泻,低血钾,胃酸缺乏症)综合征:临床特征,诊断和治疗。

获取原文
获取原文并翻译 | 示例
       

摘要

WDHA (watery diarrhea, hypokalemia, and achlorhydria) syndrome is an unusual paraneoplastic condition caused by excess vasoactive intestinal polypeptide (VIP) secreted by certain tumors. The onset of the syndrome is insidious, and diagnosis is usually delayed by months to years. Morbidity and mortality from untreated WDHA syndrome are related to long-standing dehydration and electrolyte and acid-base disturbances resulting in chronic renal failure. Diagnosis requires documentation of large volumes of secretory diarrhea, elevated serum VIP levels, and localization of the VIP-secreting tumor. Treatment includes correction of volume, electrolyte, and metabolic abnormalities, pharmacotherapy to decrease gastrointestinal secretion and increase absorption, and ultimately surgical resection or debulking of the vipoma.
机译:WDHA(水性腹泻,低钾血症和胃酸缺乏症)综合征是由某些肿瘤分泌的过量血管活性肠多肽(VIP)引起的异常副肿瘤病。该综合征的发作是隐性的,并且诊断通常延迟数月至数年。未经治疗的WDHA综合征的发病率和死亡率与长期脱水以及导致慢性肾功能衰竭的电解质和酸碱紊乱有关。诊断需要大量分泌性腹泻,血清VIP含量升高以及VIP分泌肿瘤的定位的记录。治疗包括纠正体积,电解质和代谢异常,药物治疗以减少胃肠道分泌并增加吸收,以及最终通过外科手术切除或减灭病毒瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号